Commit To Buy Cellular Biomedicine Group At $10, Earn 17.2% Annualized Using Options
January 26, 2016 at 11:56 AM EST
Investors considering a purchase of Cellular Biomedicine Group Inc (CBMG) shares, but cautious about paying the going market price of $12.40/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the September put at the $10 strike, which has a bid at the time of this writing of $1.10..